Engineers Gate Manager’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,294
Closed -$24K 1564
2022
Q2
$24K Buy
+14,294
New +$24K ﹤0.01% 1817
2021
Q2
Sell
-39,100
Closed -$208K 1562
2021
Q1
$208K Buy
+39,100
New +$208K 0.01% 1578